Team Research Forum: Utilizing BioAMS in Research and Clinical Settings – Office of Research
Join the UC Davis Office of Research in a discussion with Dr. Bruce Buchholz, a Senior Scientist at Lawrence Livermore National Laboratory (LLNL) about utilizing Biological Accelerator Mass Spectrometry (BioAMS) in research and clinical settings. For 30 years, LLNL has led the world in applying this ultra-sensitive quantitative technique in basic research and clinical studies.
Register for this event
Lawrence Livermore National Laboratory (LLNL) is a premier research and development institution for science and technology applied to national security needs. LLNL, is one of the seventeen U.S. Department of Energy national laboratories, that applies its expertise to preventing the spread and use of weapons of mass destruction and to strengthening homeland security, as well as enhancing biomedical research that directly improves the well-being of our armed forces and the nation. Our national security mission requires special multidisciplinary capabilities that are also used to pursue programs in advanced defense technologies, energy, environment, human health, and basic sciences to meet important national needs.
From the first biological Accelerator Mass Spectrometry (BioAMS) studies conducted 30 years ago, LLNL has led the world in applying the ultra-sensitive quantitative technique in basic research and clinical studies. This presentation will describe applications of AMS from published examples, describe how it differs from conventional mass spectrometry, and how to use it to approach problems with sensitivity. Applications from Absorption, Distribution, Metabolism, and Elimination (ADME) studies, pharmacokinetics, and adduct formation will be highlighted. Procedures for accessing the NIH-funded User Resource for Biological AMS and receiving free measurements will be described.
